View Document Preview and Link
Document Date: 2014-10-28 21:24:17 Open Document File Size: 479,69 KB Share Result on Facebook
City Sydney / Melbourne / / Company Pfizer Australia Pty Limited / Applied Genetic Diagnostics / / Continent Europe / / Country Sweden / Japan / Australia / Portugal / / Currency pence / USD / / Event FDA Phase / / Facility Westmead Hospital / Amyloid Clinic / University of Melbourne / Westmead Amyloidosis Clinic / / IndustryTerm patient / co-dependent technology / draft protocol / Co-dependent technologies / final protocol / trademarked technology / pharmaceuticals / genetic testing services / non-specific site / healthcare resources / draft decision analytic protocol / in-vitro diagnostic devices / / MedicalCondition carpal tunnel syndrome / sensory dissociation / less autonomic dysfunction / cardiomegaly / TTR’s dissociation / Polyneuropathy / cardiac dysfunction / transthyretin familial amyloid polyneuropathy / relatively low autonomic dysfunction / high autonomic dysfunction / familial amyloid polyneuropathy / disease / heart enlargement / orthostatic hypotension / pain / TTR-FAP disease / dehydration / / Organization University of Melbourne / Pharmaceutical Benefits Advisory Committee / National Pathology Accreditation Advisory Council / National Science Foundation / Therapeutic Goods Administration / National Association of Testing Authorities / European Medicines Agency / Westmead Hospital / Department of Health / Medical Services Advisory Committee / / Person Ageing / / Position specialist pathologist / Prime Minister / Minister / consultant physician / Governor / specialist physician / / Product TGA1 / / Technology 1222 Final Decision Analytic Protocol / draft decision analytic protocol / diagnostic tests / trademarked technology / transplantation / co-dependent technology / draft protocol / DNA sequencing / Co-dependent technologies / final protocol / / URL http / SocialTag